Giant Cell Tumor of the Uterus: Case Report and Response to Chemotherapy
Author Information
Author(s): Skubitz Keith M, Manivel J Carlos
Primary Institution: University of Minnesota Medical School
Hypothesis
The role of chemotherapy in metastatic giant cell tumors (GCT) is not well defined.
Conclusion
Aggressive metastasizing GCT may arise in the uterus, and may respond to combination chemotherapy.
Supporting Evidence
- The tumor showed a response to chemotherapy after the first cycle.
- CT imaging revealed tumor regression after treatment.
- The patient underwent a total abdominal hysterectomy after chemotherapy.
Takeaway
A woman had a rare and aggressive tumor in her uterus that spread to her lungs, but she got better after receiving special chemotherapy.
Methodology
The patient was treated with pegylated-liposomal doxorubicin, ifosfamide, and bevacizumab, with cycles repeated every 28 days.
Potential Biases
Potential conflicts of interest due to the authors' involvement in trials with related drugs.
Limitations
The role of chemotherapy in GCT is not well defined, and the long-term effectiveness of the treatment remains uncertain.
Participant Demographics
A 55-year-old woman with a history of hypertension and hypothyroidism.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website